Search - tctmd.com

Displaying 1 - 20 of 135

Sort: Relevancy | Date

News Conference News TCT 2025

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

Yael L. Maxwell

November 04, 2025

Presentation TCT 2025

From Anatomy to Outcome: Optimizing Device Selection in Transcatheter Tricuspid Therapy

Presenter: Azeem Latib

October 28, 2025

Presentation TCT 2025

MAGICAL ISR and SV: The US IDE Trials Landscape

Presenter: Azeem Latib

October 27, 2025

Presentation TCT 2025

Luna™ TMVR: 28-French Transseptal TMVR System: Technology Description and Early Clinical Results

Presenter: Azeem Latib

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Todd Neale

October 26, 2025

Presentation TCT 2025

TRESECT™: Game-Changing Device Enabling Simultaneous Leaflet Resection and Extraction (Tresquare Technologies)

Presenter: Azeem Latib

October 25, 2025

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

Navitor Vision Overview

Presenter: Azeem Latib

October 29, 2024

Presentation TCT 2024

TTVR – is the Future! Lessons from Clinical Trials and Case Experiences

Presenter: Azeem Latib

October 29, 2024

Presentation TCT 2024

Half Moon: Technology and Early Human Experience

Presenter: Azeem Latib

October 29, 2024

Presentation TCT 2024

Current DCB Landscape in the USA: Challenges and Opportunities

Presenter: Azeem Latib

October 28, 2024

Presentation TCT 2023

Progress in Embolic Protection 2: New Aortic Arch Deflectors Devices

Presenter: Azeem Latib

October 26, 2023

Presentation TCT 2023

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

Navitor: Early US Clinical Experience and Update From the Navitor Study

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

DCB’s in Clinical Practice: What US Operators Need to Know (and Have Been Missing)

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

Trans-septal Chordal Replacement Design and Early Experience: How to Make It Reproducible?

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

DurAVR Transcatheter Heart Valve: Early Feasibility Study

Presenter: Azeem Latib

October 24, 2023

Advertisement

DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES

From Anatomy to Outcome: Optimizing Device Selection in Transcatheter Tricuspid Therapy

MAGICAL ISR and SV: The US IDE Trials Landscape

Luna™ TMVR: 28-French Transseptal TMVR System: Technology Description and Early Clinical Results

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

TRESECT™: Game-Changing Device Enabling Simultaneous Leaflet Resection and Extraction (Tresquare Technologies)

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Navitor Vision Overview

TTVR – is the Future! Lessons from Clinical Trials and Case Experiences

Half Moon: Technology and Early Human Experience

Current DCB Landscape in the USA: Challenges and Opportunities

Progress in Embolic Protection 2: New Aortic Arch Deflectors Devices

Current Treatment of In-Stent Restenosis: What the Rest of the World Does

Navitor: Early US Clinical Experience and Update From the Navitor Study

DCB’s in Clinical Practice: What US Operators Need to Know (and Have Been Missing)

Trans-septal Chordal Replacement Design and Early Experience: How to Make It Reproducible?

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

DurAVR Transcatheter Heart Valve: Early Feasibility Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content